Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Eckert Patricia | 0001952777 | Nov-15-2022 | officer: Interim CFO |
Wolf James G. | 0001419248 | Oct-28-2022 | 10 percent owner |
Cannon Kara | 0001913009 | Mar-24-2022 | officer: Chief Operating Officer |
Radoff Bradley Louis | 0001380585 | Jan-03-2022 | director |
Erfanian Hamid | 0001893172 | Nov-08-2021 | officer: Chief Executive Officer |
Walters Ian B. | 0001834415 | Nov-25-2020 | director |
TAGLIAFERRI MARY | 0001323304 | Nov-17-2020 | director |
CLEMENS PETER J IV | 0001199421 | Feb-12-2020 | 10 percent owner |
Fischer Rebecca J. | 0001798758 | Dec-30-2019 | director |
Bench David | 0001797876 | Dec-23-2019 | officer: CHIEF FINANCIAL OFFICER |
BLANK FABIAN | 0001788939 | Sep-17-2019 | 10 percent owner, other: See Remarks |
HARBERT RAYMOND J | 0001233571 | May-20-2019 | 10 percent owner |
HARBERT MANAGEMENT CORP | 0001259933 | May-20-2019 | 10 percent owner |
HARBERT FUND ADVISORS, INC. | 0001616659 | May-20-2019 | 10 percent owner |
Harbert Discovery Fund, LP | 0001626127 | May-20-2019 | 10 percent owner |
BRYANT JOHN F. | 0001642336 | May-20-2019 | 10 percent owner |
LUCAS KENAN | 0001642389 | May-20-2019 | 10 percent owner |
HARBERT DISCOVERY FUND GP, LLC | 0001642538 | May-20-2019 | 10 percent owner |
HARBERT DISCOVERY CO-INVESTMENT FUND I, LP | 0001771491 | May-20-2019 | 10 percent owner |
HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC | 0001771499 | May-20-2019 | 10 percent owner |
Hanna Bruce A. | 0001694674 | Jan-05-2017 | director |
O'Brien James Michael | 0001632111 | Mar-14-2016 | officer: SVP of Finance |
Perlysky Dov | 0001072922 | Jan-06-2016 | director |
BORTZ GREGORY M. | 0001483164 | Jan-06-2016 | director |
KASTEN BERNARD L | 0001244745 | Oct-23-2014 | director |
Whiteley Andrew P | 0001520777 | Jun-02-2011 | officer: VP BusDev-COO Enzo Lif Sci Inc |
KRENITSKY KEVIN | 0001457809 | Mar-02-2009 | officer: President, Enzo Clinical Labs |
FISCHETTE CHRISTINE | 0001423674 | Jan-03-2008 | officer: President, Enzo Therapeutics |
Kent Stephen B H | 0001387811 | Jan-23-2007 | director |
BALEZENTIS CARL W | 0001286811 | Jun-05-2006 | officer: Pres., Enzo Life Sciences, Inc |
Crescenzo Andrew R. | 0001363902 | May-18-2006 | officer: Senior Vice President Finance |
Conant Marcus | 0001296374 | Jul-15-2004 | director |
WARSHAWSKY STANFORD S | 0001274817 | May-03-2004 | other: 01/2004, Resigned as Director |
RABBANI SHAHRAM K | 0000901501 | Mar-08-2004 | director, officer: COO, Treasurer & Secretary |
WEINER BARRY W | 0000901503 | Mar-08-2004 | director, officer: President and Director |
RABBANI ELAZAR | 0000903568 | Mar-08-2004 | director, officer: Chairman of the Board and CEO |
THALENFELD BARBARA E | 0001236358 | Mar-08-2004 | officer: VP Corporate Development |
GOLDBERG DAVID C | 0001251336 | Mar-08-2004 | officer: VP, Business Development |
KELKER NORMAN E | 0001251895 | Mar-08-2004 | officer: Senior Vice President |
ENGELHARDT DEAN | 0001263101 | Mar-08-2004 | officer: Executive Vice President |
BASS HERBERT B | 0001283546 | Mar-08-2004 | officer: Vice President, Finance |
GERSON IRWIN | 0001181974 | Jan-15-2004 | director |
LAZAR MELVIN F | 0001218403 | Jan-15-2004 | director |
DELUCCA JOHN | 0001263102 | Jan-15-2004 | director |
SIAS JOHN B | 0001263104 | Jan-15-2004 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ENZO BIOCHEM INC
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-017640 ( Act) Size: 8 KB |
Feb-27-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-017523 ( Act) Size: 5 KB |
Feb-27-2024 | |
8-K | Document | Current report filing Acc-no: 0001213900-24-017519 (34 Act) Size: 189 KB |
Feb-27-2024 | 24686463 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-023141 (34 Act) Size: 55 KB |
Feb-14-2024 | 24633667 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001037389-24-000010 (34 Act) Size: 13 KB |
Feb-13-2024 | 24622967 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-009795 ( Act) Size: 4 KB |
Feb-02-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-009794 ( Act) Size: 4 KB |
Feb-02-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-009793 ( Act) Size: 5 KB |
Feb-02-2024 | |
8-K | Document | Current report filing Acc-no: 0001213900-24-008745 (34 Act) Size: 229 KB |
Feb-01-2024 | 24585138 |
DEFR14A | Document | Definitive revised proxy soliciting materials Acc-no: 0001213900-23-097728 (34 Act) Size: 1105 KB |
Dec-21-2023 | 231505933 |
ARS | Document | Annual report to security holders Acc-no: 0001140361-23-058917 (34 Act) Size: 1097 KB |
Dec-21-2023 | 231505458 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-23-096093 (34 Act) Size: 4772 KB |
Dec-15-2023 | 231490505 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-23-096070 ( Act) Size: 4 KB |
Dec-15-2023 | |
10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001213900-23-090618 (34 Act) Size: 643 KB |
Nov-28-2023 | 231447494 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001213900-23-083566 (34 Act) Size: 7502 KB |
Nov-03-2023 | 231377266 |
NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001213900-23-081606 (34 Act) Size: 32 KB |
Oct-31-2023 | 231361803 |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001213900-23-081578 ( Act) Size: 6 KB |
Oct-30-2023 | |
8-K | Document | Current report filing Acc-no: 0001213900-23-081566 (34 Act) Size: 329 KB |
Oct-30-2023 | 231360995 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-23-099745 (34 Act) Size: 63 KB |
Sep-11-2023 | 231248443 |
8-K | Document | Current report filing Acc-no: 0001213900-23-074469 (34 Act) Size: 215 KB |
Sep-07-2023 | 231240512 |
Recent 20 filings. View all ENZO BIOCHEM INC filings
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by